Novartis (NOVN SW) says Kisqali shows 29.1% risk reduction in distant disease-free survival

17 Oct 2025 - 13:01- Equities- Source: Newswires

Novartis AGPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals (Group)PharmaceuticalsSMISwitzerlandNOVNSwiss Market IndexEquitiesEU SessionUS SessionUS SessionEU Session

Subscribe Now to Newsquawk

Click here for a 1 week free trial

Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include: